Stay updated on Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Site revision history shows an addition of v3.5.0 and a deletion of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T23:30:45.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:21:19.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study record shows new update dates (2026-02-12, 2026-02-17, 2026-08-15) and the field 'Product Manufactured in and Exported from the U.S.' has been removed.
    Difference
    0.5%
    Check dated 2026-02-19T04:52:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:23:50.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.4.1 appears in the page footer, replacing v3.4.0; no other changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:54:45.000Z thumbnail image
  9. Check
    76 days ago
    Change Detected
    Summary
    Show glossary has been added to the page. Metadata/UI strings related to QC criteria updates and versioning were updated (e.g., 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'), including capitalization tweaks for 'No FEAR Act Data'.
    Difference
    0.2%
    Check dated 2026-01-28T21:26:41.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.